Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:39:14 EDT Sat 04 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Z:NBY
- NOVABAY PHARMACEUTICALS INC -
https://investors.novabay.com/
07:39:14 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
NBY
- Z
0.1
0.0805
·
0.0923
1.3
0.0949
+0.0022
2.4
1,479.5
110
590
0.0915
0.10
0.09
1.28 0.065
19:59:43
06:50
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
Company
·
Participants
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 590
More trades...
Time ET
Ex
Price
Change
Volume
19:59:43
Z
0.0925
0.0025
2
19:59:27
Z
0.0925
0.0025
1
19:59:12
Z
0.0923
0.0023
1
19:58:19
Z
0.0923
0.0023
1
19:57:24
Z
0.0925
0.0025
1
19:57:08
Z
0.0925
0.0025
1
19:56:50
Z
0.0923
0.0023
1
19:56:40
Z
0.0923
0.0023
1
19:56:31
Z
0.0925
0.0025
1
19:56:22
Z
0.0925
0.0025
1
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-05-03 06:50
U:NBY
News Release
200
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
2024-04-22 06:57
U:NBY
News Release
200
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
2024-04-19 18:00
U:NBY
News Release
200
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
2024-04-17 06:59
U:NBY
News Release
200
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
2024-03-29 02:38
U:NBY
SEDAR MD & A
815
SEDAR MD & A
2024-03-29 02:31
U:NBY
SEDAR Annual Information Form
802
SEDAR Audited Annual Financial Statements
2024-03-26 16:05
U:NBY
News Release
200
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
2024-03-25 18:38
U:NBY
News Release
200
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
2024-03-14 08:00
U:NBY
News Release
200
NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
2024-03-13 07:00
U:NBY
News Release
200
NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals
2024-01-30 09:00
U:NBY
News Release
200
NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
2024-01-09 09:16
U:NBY
News Release
200
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma ¢ € ™s Extensive Distributor Network
2023-12-06 06:50
U:NBY
News Release
200
NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes
2023-11-09 17:00
U:NBY
SEDAR Interim Financial Statements
812
SEDAR Interim Financial Statements
2023-11-09 16:50
U:NBY
SEDAR Interim MD & A
813
SEDAR Interim MD & A
2023-11-09 16:05
U:NBY
News Release
200
NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
2023-11-02 06:50
U:NBY
News Release
200
NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
2023-10-11 08:00
U:NBY
News Release
200
NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs
2023-10-02 06:50
U:NBY
News Release
200
NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference